Document is current
Any future updates will be listed below
-
Authors
Pan, Long https://orcid.org/0000-0003-1550-8280
Hirsch, Théo Z. https://orcid.org/0000-0003-4428-2997
Fang, Jing
Seretny, Agnieszka
Imbeaud, Sandrine https://orcid.org/0000-0001-8439-6732
Jin, Shuoshuo
Gege, Olatunji Oluwole https://orcid.org/0009-0003-0800-0507
Rebouissou, Sandra
Sidali, Sabrina
Ammiche, Naïma
Calderaro, Julien
Amaddeo, Giuliana
Blanc, Jean-Frédéric
Le Bail, Brigitte
Ziol, Marianne https://orcid.org/0000-0001-5117-4842
Celton-Morizur, Séverine
Paradis, Valérie https://orcid.org/0000-0003-3142-3762
Llovet, Josep M. https://orcid.org/0000-0003-0547-2667
Tschaharganeh, Darjus Felix
Nault, Jean-Charles
Desdouets, Chantal https://orcid.org/0000-0002-1955-8915
Caruso, Stefano
Zucman-Rossi, Jessica https://orcid.org/0000-0002-5687-0334
- License Information
-
More Information
Article History
Received: 20 February 2025
Accepted: 5 May 2026
First Online: 19 May 2026
Competing interests
: J.M.L. received research support from Genentech and Roche; consultancy or lecture fees from Eisai Inc., Merck, Roche, Genentech, AstraZeneca, Bayer Pharmaceuticals, AbbVie, Sanofi, Moderna, Glycotest, Exelixis, and Boehringer Ingelheim; and served on a Data Safety Monitoring Board for Bristol Myers Squibb. J.C.N. received grants from Ipsen and Bayer. The remaining authors declare no competing interests.
